Literature DB >> 33956620

Cutaneous Manifestation as Initial Presentation of Metastatic Breast Cancer: A Systematic Review.

Cassandra Johnson1, Daniel P Friedmann1, Anita Gade1, Naveen Dhawan1, Kathryn Hinchee-Rodriguez1, Vineet Mishra1, Sofia Rodriguez1, Matthew Apicella1.   

Abstract

Metastatic breast cancer initially may present with cutaneous lesions. The goal of this systematic review was to evaluate available reports where the initial discovery of primary breast cancer occurred through the diagnosis of metastatic cutaneous lesions. We aimed to better understand these cases and the role of dermatologists in their diagnosis. A review of the literature for case reports and retrospective studies was conducted using the following databases: MEDLINE/PubMed, EMBASE, Cochrane library, CINAHL, and EBSCO. The PRISMA guidelines were utilized. Studies were included if they reported a cutaneous metastasis of a primary breast cancer in females. Studies were excluded if skin metastasis occurred in a patient with a history of breast cancer. Thirty-six publications were identified. Among these, 27 were case reports, and 9 were retrospective reviews. An enhanced understanding of how these cutaneous metastases present may be of clinical benefit to physicians, particularly dermatologists.

Entities:  

Year:  2021        PMID: 33956620     DOI: 10.12788/cutis.0223

Source DB:  PubMed          Journal:  Cutis        ISSN: 0011-4162


  2 in total

1.  Cutaneous Breast Cancer Metastasis Is Effectively Treated With Intralesional Interleukin-2 and Imiquimod: A Case Report and Brief Literature Review.

Authors:  Ashley Drohan; Dejan Vidovic; Penelope Jane Barnes; Carman Anthony Giacomantonio; Lucy Kathryn Helyer
Journal:  Front Oncol       Date:  2022-05-30       Impact factor: 5.738

2.  Differences in the Molecular Profile between Primary Breast Carcinomas and Their Cutaneous Metastases.

Authors:  Silvia González-Martínez; David Pizarro; Belén Pérez-Mies; Tamara Caniego-Casas; José Luis Rodríguez-Peralto; Giuseppe Curigliano; Alfonso Cortés; María Gión; Javier Cortés; José Palacios
Journal:  Cancers (Basel)       Date:  2022-02-23       Impact factor: 6.639

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.